A dopaminergic system in the zona incerta stimulates LH release and may mediate the positive feedback effects of the gonadal steroids on LH release. In this study the mechanisms by which steroids might increase dopamine activity in the zona incerta were investigated. In addition, experiments were conducted to determine whether the inhibitory effects of gamma-aminobutyric acid (GABA) on LH release in the zona incerta are due to suppression of dopamine activity in this area or conversely whether the stimulatory effects of dopamine on LH release are due to suppression of a tonic inhibitory GABAergic system. Ovariectomized rats were treated s.c. with oil, 5 \ g=m\ g oestradiol benzoate or 5 \ g=m\ g oestradiol benzoate followed 48 h later by 0.5 mg progesterone, and killed 54 h after the oestradiol benzoate injection. At this time the LH concentrations were suppressed in the oestradiol benzoate group and increased in the group treated with oestradiol benzoate and progesterone. The ratio of tyrosine hydroxylase:\g=b\-actin mRNA in the zona incerta was significantly increased by the oestradiol benzoate treatment, but the addition of progesterone resulted in values similar to those in the control group. At the same time, the progesterone treatment increased tyrosine hydroxylase activity in the zona incerta as indicated by an increase in l-dihydroxyphenylalanine (l-DOPA) accumulation after 100 mg 3-hydroxybenzylhydrazine hydrochloric acid (NSD1015) kg\m=-\1 and an increase in dopamine release as indicated by a increase in dihydroxyphenylacetic acid (DOPAC) concentrations (one of the major metabolites of dopamine). Ovariectomized rats treated with oestradiol benzoate plus progesterone were also injected i.p. with 75 mg gamma-acetylenic GABA kg\ m=-\ 1(a GABA transaminase inhibitor) to increase GABA concentrations in the brain. This treatment had no effect on the ratio of tyrosine hydroxylase:\g=b\-actin mRNA but decreased l-DOPA accumulation and DOPAC concentrations in the zona incerta, indicating a post-translational inhibition of dopamine synthesis and release. Treatment of ovariectomized rats with oestradiol benzoate followed by 100 mg l-DOPA i.p. to increase dopamine concentrations in the whole brain had no effect on glutamic acid decarboxylase mRNA expression in the zona incerta, although it increased the glutamic acid decarboxylase:\g=b\-actin mRNA ratio in other hypothalamic areas (that is, the medial preoptic area, ventromedial nucleus and arcuate nucleus). In conclusion, the steroids act to increase dopamine activity in different ways: oestrogen increases tyrosine hydroxylase mRNA expression and progesterone acts after translation to increase tyrosine hydroxylase activity and dopamine release (as indicated by increases in DOPAC concentrations). This latter effect may be due to progesterone removing a tonic GABAergic inhibition from the dopaminergic system.
Introduction
The zona incerta situated in the dorsal hypothalamus is an important integrating centre, receiving and conveying neuronal tracts from the spinal cord, mid-brain, thalamus, cortex and limbic system (Ricardo, 1981; Eaton et al, 1994; 1995; May et al, 1997) . Oestrogen receptors (of both the and ß type) are present in the zona incerta (Sar, 1984; Shrughrue et al, 1997) as are steroid metabolizing enzymes (Haglund et al, 1984) , and this area regulates steroid-dependent functions such as gonadotrophin release (MacKenzie et al, 1984; James et al, 1987; Sanghera et al, 1991a) and male and female sexual behaviour (Dornan et al, 1991; Wilson et al, 1991) .
The zona incerta forms part of the dopaminergic incertohypothalamic tract that originates from three nuclear areas of dopamine cell bodies termed All, A13 and A14 (Bjorklund and Nobin, 1973) . The cell bodies of the All group are sited in the caudal thalamus and their terminals reach the medialanterior part of the zona incerta. The Al 3 group are present in the zona incerta close to these nerve terminals and immunocytological techniques reveal that their axons lead to various hypothalamic nuclei, that is, the dorsal medial nucleus, paraventricular nucleus, lateral hypothalamus and anterior hypothalamus (Bjorklund and Nobin, 1973; Bjorklund et al, 1975) . There is controversy as to whether the preoptic area is innervated by dopamine neurones from the zona incerta (Bjorklund et al, 1975; Day et al, 1980) , but if they are present, they do not impinge on GnRH neurones (Horvath et al, 1993) . The anterograde tracer technique shows that neurones in the zona incerta project ipsilaterally to the paraventricular nucleus, anterior hypothalamus, ventromedial nucleus, supraoptic nucleus, arcuate nucleus and medial preoptic area (Wagner et al, 1995) , but these are not necessarily dopaminergic and may belong to other neuronal systems originating in the zona incerta; examples include gamma-aminobutyric acid (GABA) (Oertel et al, 1982) , adrenaline (Ross et al, 1984) , aspartate (Moga and Moore, 1996) , melanin concentrating hormone (MCH) (Bittencourt et al, 1992) and orexin (Sakurai et al, 1998 ).
The dopamine system in the zona incerta exerts a stimulatory effect on the secretion of LH, since application of dopamine into the zona incerta stimulates LH release, whereas dopamine antagonists have the opposite effect (MacKenzie et al, 1984; James et al, 1987) . This action is probably of physiological significance, since selective lesions of the dopaminergic nerve terminals in the zona incerta and lesions of all the cell bodies in this area prevent normal oestrous cyclicity (MacKenzie et al, 1984 (MacKenzie et al, ,1988 and electrolytic lesions prevent the pro-oestrous preovulatory LH surge (Sanghera et al, 1991a) and decrease concentrations of GnRH in the median eminence (Wilkes et al, 1979) . Conversely, dopamine turnover in the zona incerta increases at the time of the preovulatory LH surge in intact female rats and the LH surge induced by ovarian steroids in ovariectomized rats (MacKenzie et al, 1988; Wilson et al, 1991) .
GABA neurones in the zona incerta also regulate LH release. Administration of GABA agonists into the zona incerta results in inhibition of LH release, whereas antagonists have the opposite effect (Wilson et al, 1990 ). Furthermore, ovarian steroid treatment reduces the expression of the rate-limiting synthetic enzyme glutamic acid decarboxylase (GAD) in the zona incerta at the time of the expected increase in LH secretion (Leigh et al, 1990 ).
The observations that administration of oestradiol benzoate and progesterone to ovariectomized rats can alter dopamine turnover and glutamic acid decarboxylase mRNA expression in the zona incerta at the same time as stimulating release of LH indicate that dopamine and GABA may mediate ovarian steroid regulation of the cyclical release of LH. The aim of the present study was to elucidate the mechanisms by which the steroids might alter dopaminergic activity in the zona incerta and to determine whether their effects are exerted on mRNA expression or posttranslationally or on other events along the pathway. In addition, the possible interaction between the dopaminergic and GABAergic systems in the zona incerta was investigated. Whole brain GABA concentrations were increased and any changes in dopamine activity in the zona incerta were recorded. Conversely, whole brain dopamine concentrations were increased and changes in glutamic acid decarboxylase mRNA expression were measured. The modulation of these possible interactions by ovarian steroids was considered.
Materials and Methods

Animals
Female Wistar rats (180-220 g) bred at St George's Hospital Medical School were ovariectomized under halothane (Fluothane, Zeneca Ltd, Macclesfield) and nitrous oxide anaesthesia and allowed to recover for at least 2 weeks before experimentation. The rats were housed in groups of five in a fixed lighting system (lights on 07:00 h to 19:00 h) and given food and water ad libitum.
General procedures and treatments
There were three treatment groups in each experiment and treatment was initiated at 12:00 h. Rats were treated s.c. with either 0.1 ml corn oil, 5 µg oestradiol benzoate in 0.1 ml oil, or 5 µg oestradiol benzoate followed 48 h later by either 0.1 ml oil or 0.5 mg progesterone in 0.1 ml oil. At 6 h after progesterone or 54 h after the first injection of oil or oestradiol benzoate, the animals were decapitated. Blood was collected from the cervical cut and the brain was removed, placed immediately in solid C02, and stored at -80°C or frozen in liquid nitrogen-cooled isopentane for subsequent mRNA extraction. The blood samples were centrifuged at 400 g at 4°C for 15 min and the plasma was stored at -20°C until assayed for LH.
In one experiment, groups of ovariectomized rats were treated with oestradiol benzoate alone and killed at 0, 6, 24, 30, 48, 51 or 54 h after the oestradiol benzoate injection (that is, at 12:00 or 18:00 h on day 1,12:00 or 18:00 h on day 2 and 12:00, 15:00 or 18:00 h on day 3). Groups of oil-treated rats were killed at 12:00,15:00 and 18.00 h to serve as controls for a possible circadian rhythm.
Other treatments included 3-hydroxybenzylhydrazine hydrochloric acid (NSD1015, 100 mg kg1 i.p.; Sigma Chemical Co. Ltd, Poole), an aromatic-acid decarboxylase inhibitor, administered 20 min before the animals were killed. This time was chosen after determination of the rate of accumulation of L-3,4-dihydroxyphenylalanine (l-DOPA) in the zona incerta during 10-60 min after NSD1015, which showed that accumulation reached a plateau only after 30 min. The GABA transaminase inhibitor, gamma-acetylenic GABA (GAG; Merrell Dow Labs, Strasbourg) was administered (75 mg kg-1 i.p.) 1 h after progesterone, that is 5 h before the rats were killed. The dopamine precursor L-DOPA (Sigma Chemical Co. Ltd, Poole) was administered (100 mg kg-1 i.p.) to the oestradiol benzoate-treated group at 60 min before the rats were killed, to raise whole brain concentrations of dopamine.
Preparation of brain samplesfor analysis
Microdissection of the zona incerta was carried out according to the method of Palkovits (1973) using a flattipped needle of 0.7 mm diameter as the punch. Other areas were dissected at the same time, including the preoptic area, ventromedial nucleus and arcuate nucleus; all sites were identified according to Paxinos and Watson (1982) . Samples were stored at -80CC until analysed for amines within 4 weeks. In the case of mRNA assessment, RNA extraction was carried out immediately after the microdissection.
HPLC and electrochemical detection
Dopamine and dihydroxyphenylacetic acid (DOPAC). The micropunch samples were sonicated in cold 0.1 mol perchloric acid H (HPLC grade; Merck, Lutterworth) containing 0.01 µg isoprenaline as the internal standard. After centrifuging at 11000 g for 15 min, 50 µ supernatant was injected via a Rheodyne 7125 injection valve into a Beckman ultrasphere ion-pair 5 pm column (15 cm 4.6 mm) protected by a guard column (Uptight Pre-column Kit-C-135ß; Jones Chromatograph Ltd, Hengoed). The dopamine and DOPAC were detected using an LC4C amperometric detector (BAS Technicol Ltd, Congleton) set in oxidative mode with a potential of + 0.7 V versus an Ag-AgCl reference electrode (Model TL5A; BAS Technicol). The mobile phase consisted of filtered and de-gassed 0.1 mol citric acetate \\ 25 mmol NaOH H and 1 mmol EDTA-Na L1 (pH 3.55) containing 0.5 mmol octane sulphonate I"1 as the ion-pair reagent and 6% (v/v) acetonitrile.
Chromatograms were analysed by a Schimadzu CR3A Chromatopac integrator (Shimadzu UK, Milton Keynes) and the sensitivity was 10-15 pg for dopamine and DOPAC dependent upon laboratory conditions. Protein content was estimated on the remaining pellet after extraction with perchloric acid, using the modified Coomassie blue method of Bradford (1976). l-DOPA All details were as described above except the mobile phase consisted of 0.1 mol citric acetate buffer 1_1 at pH 4.85 containing 1.1 mmol heptane sulphonate I""1 and 3% methanol. The internal standard was dihydroxyphenylglycol (Sigma Chemical Co. Ltd, Poole). The l-DOPA was detected by the Coulochem electrochemical detection (ESA Analytical, St Ives, Huntingdon) and the chromatograms were analysed by a Spectra-Physics SP4270 integrator (Thermo Separation Products, Stone). The sensitivity for l-DOPA was 25 pg.
RNA extraction and slot-blot analysis oftyrosine hydroxylase, glutamic acid decarboxylase and ß-actin mRNAs Total RNA was extracted from individual micropunch samples using RNAzol (Biogenics Ltd, Bournemouth) according to the manufacturer's protocol. The quality of the extracted RNA was assessed by standard northern blotting procedures using glyoxal to denature the RNA and [32P]d-CTP-labelled (Amersham International, Amersham) tyrosine hydroxylase cDNA (Tufts University, Boston, USA), glutamic acid decarboxylase 67 cDNA (UCLA, USA) or ß-actin (Galton Laboratories, University College London; used as a 'house-keeping' gene) as the probes. The signal obtained from autoradiography was discrete, indicating undegraded RNA, and the size of the mRNA molecule hybridized with the relevant probe corresponded to published values (Leigh et al, 1990; Lewis et al, 1983) .
The RNA derived from each micropunch sample was applied in 100 µ sterile water to a nylon membrane (Zetaprobe; Bio-Rad, Hercules, CA) using a manifold slotblot apparatus (Schleicher & Schuell, Dassel). The filters were baked at 80°C for 1 h to fix the RNA, prehybridized and then hybridized overnight at 42°C with either [32P]d-CTPlabelled tyrosine hydroxylase cDNA or glutamic acid decarboxylase 67 cDNA. For rehybridization, the probes were stripped off the filter by washing in boiling 0.1 SSC (saline sodium citrate)-0.1% (w/v) SDS and cooling gradually to room temperature. The filter was subjected to autoradiography to ensure that all the probe had been removed. After prehybridization, the filter was rehybridized with [32P]d-CTP-labelled ß-actin.
The filters were washed with solutions containing SSC and SDS. The stringency of washing was increased gradually by decreasing the SSC concentration and increasing the temperature; the final wash was carried out using 0.1 SSC-0.1% (w/v) SDS at 60°C for 5 min. The filters were subjected to autoradiography with X-0mat-AR X-ray film for periods of up to 2 weeks. The film was developed using Kodak developer and fixer. The intensity of the bands obtained after autoradiography was measured using a scanning densitometer (Chromoscan 3; Joyce Loebl, Gateshead). Results were expressed as a ratio of peak intensity obtained after hybridization with tyrosine hydroxylase cDNA probe:ß-actin cDNA probe or glutamic acid decarboxylase 67 cDNA probe:ß-actin cDNA probe.
Radioimmunoassayfor plasma LH
The assay was conducted according to Kendle et al. (1978) . Plasma samples (10 µ ) were assayed in duplicate using reagents supplied by the National Hormone and Pituitary Program (Baltimore, MD). The standard was NIADDK-rLH-RP3 and the antibody NIADDK-anti-rLH S10. The inter-and Downloaded from Bioscientifica.com at 12/18/2018 07:07:05PM via free access intra-assay coefficients of variation were 8.0 and 9.5%, respectively, and the sensitivity was 10 pg per tube (Ing ml1).
Statistical analysis
The significance of difference between two groups was assessed by the Student's t test together with their 95% confidence limits. Comparisons among more than two groups were carried out by ANOVA followed by Gabriel's test for comparison of unequal groups.
Results
Effect of steroids on dopamine activity in the zona incerta
Expression of tyrosine hydroxylase mRNA in the zona incerta.
Ovariectomized rats were treated with either 5 pg oestradiol benzoate, which reduced LH release as noted 54 h later, or 5 µg oestradiol benzoate followed at 48 h by 0.5 mg progesterone, which stimulated LH release (Table 1) . At this time, slot-blot analysis of micropunch samples of the zona incerta showed that the expression of mRNA for tyrosine hydroxylase, the rate-limiting enzyme for catecholamines, was significantly increased by treatment with oestradiol benzoate alone. This was indicated by the ratio of tyrosine hydroxylase:ß-actin mRNA compared with that in the oiltreated animals. Administration of progesterone to the oestradiol benzoate-treated animals decreased the ratio to a value similar to that in the controls.
The tyrosine hydroxylase:ß-actin mRNA ratio at several intervals after the oestradiol benzoate treatment is shown (Table 2); only the value at 54 h after injection was significantly higher in the oestradiol benzoate-treated animals than in the controls.
Effect on tyrosine hydroxylase activity. Ovariectomized rats primed with either oil, oestradiol benzoate alone or oestradiol benzoate plus progesterone were all treated i.p. with 100 mg NSD1015 kg1 at 20 min before the animals were killed. NSD1015 is an aromatic-acid decarboxylase inhibitor and prevents the conversion of L-DOPA to dopamine. Thus the accumulation of L-DOPA in the 20 min after the NSD1015 injection is an indication of tyrosine hydroxylase activity (that is, in converting tyrosine to L-DOPA). Treatment with oestradiol benzoate alone had no effect on L-DOPA accumulation, but oestradiol benzoate plus progesterone at the time of increased LH release significantly increased L-DOPA concentrations, indicating an increase in tyrosine hydroxylase activity (Table 3) . (7) 2.72 ± 0.48»* (6) 1.00 ±0.17 (7) 1.63 ±0.09 (6) Plasma LH(ng ml"1) 7.50 ±0.43 (7) 3.43 ± 1.05* (6) 42.64 ± 6.39**f (6) 14.90 ± 0.45* (12)
Ovariectomized rats were injected s.c. with 0.1 ml oil, 5 µg oestradiol benzoate or 5 µg oestradiol benzoate followed 48 h later by 0.1 ml oil or 0.5 mg progesterone. The progesterone-treated animals were also injected i.p. with 1 ml saline kg"' or 75 mg gamma-acetylenic GABA kg-1 (GAG; gamma-acetylenic GABA; GABA inhibitor) at 1 h after the progesterone treatment. All animals were killed 54 h after oestradiol benzoate, that is, 6 h after progesterone and 5 h after GAG.
Values are mean ± SE. Numbers in parentheses represent number of micropunch samples or plasma samples in each group. *P < 0.01, **P < 0.001 compared with oil-treated controls; *P < 0.001 compared with groups treated with oestradiol benzoate alone; *P < 0.001 compared with oestradiol benzoate + progesterone group (ANOVA and Gabriel's test for multiple comparison). Values are mean ± se. Numbers in parentheses represent number of micropunch samples or plasma samples in each group. *P < 0.01 compared with oil-treated controls at the same time (Student's t test); < 0.005, *P < 0.001 compared with all other time intervals (ANOVA and Gabriel's test for multiple comparisons). (7) 10.66 ± 0.76 (7) 3.87 ± 0.81 (6) 3.70 ±0.41** (7) 5.30 ±0.32** (7) 20.41 ± 5.44**+ (4) 3.49 ± 0.45* (6) 1.97 ±0.28« (6) Treatments were as for Table 1. aL-DOPA: accumulation assessed 20 min after administration of 100 mg 3-hydroxybenzylhydrazine hydrochloric acid (NSD1015) kg"1 i.p. Values are mean ± SE. Numbers in parentheses represent number of micropunch samples in each group. *P < 0.01, **P < 0.001 compared with oil-treated controls; +P < 0.001 compared with group treated with oestradiol benzoate alone; *P < 0.01, **P < 0.001 compared with oestradiol benzoate + progesterone + saline group (ANOVA and Gabriel's test for multiple comparison).
-'Effect on dopamine and DOPACconcentrations. The concentrations of dopamine and one of its major metabolites DOPAC were measured in ovariectomized animals treated with oil, oestradiol benzoate alone or oestradiol benzoate plus progesterone. Oestradiol benzoate had no effect on the concentration of either dopamine or DOPAC, whereas in the animals treated with oestradiol benzoate plus progesterone, there was a significant increase in DOPAC concentrations at the time of the increased release of LH; dopamine concentrations were not affected by the oestradiol benzoate plus progesterone treatment (Table 4 ).
Effect ofincreasing whole brain GABA concentrations on dopaminergic activity in the zona incerta
Ovariectomized animals primed with oestradiol benzoate plus progesterone were treated i.p. with either 0.1 ml saline kg-1 or 75 mg GAG kg-1 at 1 h after progesterone treatment, that is 5 h before the animals were killed. GAG is a GABA transaminase inhibitor and so increases endogenous GABA concentrations by preventing its degradation. Groups treated with oestradiol benzoate plus progesterone showed high concentrations of LH, and GAG significantly reduced these Values are mean ± se. Numbers in parentheses represent number in each group. *P < 0.01, **P < 0.001 compared with oil-treated controls; < 0.001 compared with group treated with oestradiol benzoate alone; *P < 0.01, **P < 0.001 compared with oestradiol benzoate + progesterone + saline group (ANOVA and Gabriel's test for multiple comparison).
concentrations. GAG had no effect on the ratio of tyrosine hydroxylase:ß-actin mRNA expression (Table 1) , whereas it significantly reduced L-DOPA accumulation and DOPAC concentrations in the zona incerta (Tables 3 and 4 ). The effect on DOPAC was specific to the zona incerta and did not occur in the other areas analysed (preoptic area, ventromedial nucleus and arcuate nucleus) (see Table 5 ). In addition, GAG treatment had no effect on L-DOPA accumulation in the arcuate nucleus and ventromedial nucleus, but did induce a decrease in L-DOPA in the preoptic area (Table 5 ).
Effect ofincreasing whole brain dopamine concentrations on GAD mRNA in hypothalamic areas Ovariectomized rats primed with 5 pg oestradiol benzoate were injected i.p. with 100 mg l-DOPA kg-1 at 1 h before the animals were killed. This treatment increased dopamine concentrations approximately threefold in the zona incerta, preoptic area, ventromedial nucleus and arcuate nucleus (for example, in the zona incerta, dopamine concentrations (pg pg-1 protein ± SE (n)): oestradiol benzoate + saline, 4.19 ± 0.86 (14); oestradiol benzoate + L-DOPA, 12.08 ± 3.28 (8); < 0.001), but did not significantly alter LH concentrations (LH concentrations (ng ml-1 ± SE ( )): oestradiol benzoate + saline, 3.7 ± 0.47 (16); oestradiol benzoate + L-DOPA, 3.8 ± 1.06 (8) ). The L-DOPA treatment increased GAD: ß-actin ratios to a similar extent in all areas examined, that is, there was an increase of between 1.52-and 2.07-fold in the four areas, which are all within the 95% confidence limits of each group. In comparison with the relevant saline groups, the increase was significant in all areas, except the zona incerta (Table 6 ).
Discussion
Other studies showed that administration of dopamine into the zona incerta stimulates LH release, whereas dopamine antagonists have the opposite effect (MacKenzie et al, 1984; (17) 3.75 ± 0.29* (7) 7.99 ±1.28 (8) 2.53 ± 0.16 (8) 4.37 ± 0.49 (6) 12.70 ± 3.25 (8) 2.68 ± 0.39 (9) 3.59 ± 0.34 (7) 5.72 ± 0.85 (9) 1.73 ±0.13 (9) Ovariectomized rats were injected s.c. with 5 µg oestradiol benzoate followed 48 h later with 0.5 mg progesterone. At 1 h after progesterone the rats were injected i.p. with either 1 ml saline kg-1 or 75 mg gamma-acetylenic GABA (GAG) kg-1. All animals were killed 54 h after oestradiol benzoate, that is, 6 h after progesterone and 5 h after GAG. Some animals also received 100 mg 3-hydroxybenzylhydrazine hydrochloric acid (NSD1015) kg"1 i.p. 20 min before they were killed to assess L-DOPA accumulation.
Values are mean ± SE pg µg"l protein. Number of micropunch samples in each group is given in parentheses. LH concentrations for the groups assessed for L-DOPA accumulation are shown in Table 3 and for groups assessed for dopamine and DOPAC in (7) 2.04 ± 0.45 (5) 1.82 ±0.20* (9) 2.46 ± 0.37* (8) 1.97 ±0.21* (8) exerting a negative or positive feedback effect, has no effect on dopamine activity as assessed by the above parameters (Shoemaker and Schlumpf, 1977; Gunnet et al, 1986; Wilson et al, 1991) . However, in long-term ovariectomized rats, chronic oestrogen treatment, either alone or with progesterone, restores the reduced immunoreactive tyrosine hydroxylase concentrations in dopamine neurones in the zona incerta to normal values (Sanghera et al, 1991b).
The aim of the present study was to determine the possible mechanisms by which the ovarian steroids might influence dopamine activity, that is, by affecting the expression or activity of the rate-limiting catecholamine synthetic enzyme tyrosine hydroxylase or by acting on the release of dopamine. The results showed that oestradiol benzoate alone increased expression of tyrosine hydroxylase mRNA 54 h after treatment, as indicated by the significant increase in the ratio of tyrosine hydroxylase:ß-actin mRNA, whereas the oestradiol benzoate plus progesterone treatment reversed this increase. These results are in conflict with those of Morrell et al (1989) who reported that steroid treatments had no influence on tyrosine hydroxylase mRNA (assessed by in situ hybridization) in the zona incerta. Although the steroid regimen was different from that used in the present study and no LH measurements were made when the animals were killed, Morrell et al (1989) expected to see low LH concentrations in the group treated with oestradiol benzoate alone and an LH surge in the animals treated with oestradiol benzoate plus progesterone. The animals were killed at the mid-point of the dark phase in a 12 h light:12 h dark regimen, whereas in the present study, animals were killed 1 h before the start of the dark period; this may explain the observed differences and emphasises the sensitivity of the kinetics of the system. In the present study, the LH surge was induced to occur at a time similar to the physiological timing of the natural LH surge (between 18:00 and 19:00 h, just before the transition from light to dark).
The results of the present study also showed that although progesterone appeared to reduce tyrosine hydroxylase mRNA in oestradiol benzoate-treated animals, at the same time it increased synthesis, as shown by the increase in l-DOPA accumulation, which is a marker of increased tyrosine hydroxylase activity. Progesterone also increased DOPAC concentrations, which could be interpreted as an increase in dopamine release (Tian et al, 1991) or an increase in degradative enzyme activity. Either explanation, when taken together with the increase in synthesis, indicates an increase in dopamine turnover and supports previous findings on dopamine turnover using -methyl tyrosine (MacKenzie et al, 1988; Wilson et al, 1991) . The effect of oestradiol benzoate on tyrosine hydroxylase mRNA was observed at the time of reduced LH release, whereas the effect of progesterone on dopamine turnover was observed when LH was increased. The timing of the two effects might be different; the effect on tyrosine hydroxylase mRNA may precede translational events and any other events that occur further along the transmitter pathway. A time course of the effect of oestradiol benzoate on tyrosine hydroxylase mRNA showed that the increase does not occur earlier than 54 h after treatment and is not associated with any negative feedback effect on LH, which can be observed as early as 6 h after treatment. Thus, the stimulatory effect on expression of tyrosine hydroxylase mRNA may be in preparation for the potential positive feedback effect on LH release that occurs at a later stage and after any negative feedback effect, in the presence of sufficiently high concentrations of ovarian steroids. The post-translational effect of progesterone on tyrosine hydroxylase activity may have a feedback action to terminate further increased expression of tyrosine hydroxylase mRNA.
Oestradiol benzoate receptors are present in the nuclei of neurones in the zona incerta, whereas progesterone receptors have not been observed at that site (Sar, 1984; Fox et al, 1990) .
